A new family of COVID-19 variants known as ‘FLiRT’ is now dominant in the United States. The most effective solution may be to strengthen our natural immunity.
In this episode, critical care physician Dr. Paul Marik breaks down a new study published in Nature medical journal on COVID-19 vaccine ribosomal frameshifting.
People who have moderate to severe COVID-19 prior to vaccination may have increased reactogenicity to COVID-19 vaccines, according to a Canadian study.